After a weak start and a subsequent sharp fall, stocks recovered gradually on Turnaround Tuesday, but still ended the day’s session in negative territory.
The major averages all ended notably lower, but well off the session’s lows. The Dow, which was down by about 470 points at one stage, ended the day with a loss of 158.64 points or 0.45 percent at 35,314.49.
The S&P 500 settled with a loss of 19.06 points or 0.42 percent at 4,499.38, off the day’s low of 4,464.39. The Nasdaq, which dropped to 13,769.34, ended with a loss of 110.07 points or 0.79 percent at 13,884.32.
The sharp early setback was due to concerns about global economic growth after data showed China’s exports and imports both fell more than expected in July, threatening recovery prospects and adding to pressure on policymakers to unveil additional stimulus.
In U.S. economic news, data showed U.S. trade deficit narrowed to a 3-month low of $65.5 billion in June, from a downwardly revised $68.3 billion in May. Imports fell 1 percent in the month, while exports edged down 0.1 percent.
Wholesale inventories in the United States were down 0.5 percent from a month earlier in June 2023, compared to the preliminary estimate of a 0.3 percent decrease and following an upwardly revised 0.4 percent fall in the prior month.
A report from the National Federation of Independent Business said the NFIB Small Business Optimism index rose for a third straight month to 91.9 in July, the highest reading since November 2022.
Bank shares were under pressure after Moody’s cut ratings for 10 small and midsize lenders and warned six big banks might be downgraded as well.
Salesforce.com and Goldman Sachs, both ended nearly 2% down. Travelers Companies, Wallgreens Boots Alliance, Microsoft, Intel, JP Morgan Chase, and McDonalds also ended notably lower.
Amgen shares rallied more than 3 percent. Walt Disney climbed nearly 1.5 percent. Apple, Caterpillar and Merck posted modest gains.
In overseas trading, ended Tuesday’s session on a mixed note after the release of weak Chinese trade data and ahead of key inflation readings from the world’s largest economies due this week.
European stocks closed notably lower on Tuesday, weighed down by growth worries after data showed China’s exports and imports both sank at their fastest pace sine the 2020 Covid-19 pandemic in July.
MARK LEIBOVIT INTERVIEW WITH MICHAEL CAMPBELL
https://tinyurl.com/2vzf58wk
AMERICAN ECONOMY IN MORE TROUBLE THAN WASHINGTON ADMITS
https://tinyurl.com/yc8n7n38
THE MAGNIFICENT SEVEN WITH LEIBOVIT VR CHARTS FROM THIS PAST WEEKEND
AMAZON
MSFT
GOOG
AAPL
NFLX
NVDA
META
WHO IS MARK LEIBOVIT?
MARK LEIBOVIT is Chief Market Strategist for LEIBOVIT VR NEWSLETTERS a/k/a VRTrader.Com. His technical expertise is in overall market timing and stock selection based upon his proprietary VOLUME REVERSAL (TM) methodology and Annual Forecast Model.
Mark’s extensive media television profile includes seven years as a consultant ‘Elf’ on “Louis Rukeyser’s Wall Street Week” television program, and over thirty years as a Market Monitor guest for PBS “The Nightly Business Report”. He also has appeared on Fox Business News, CNBC, BNN (Canada), and Bloomberg, and has been interviewed in Barrons, Business Week, Forbes and The Wall Street Journal and Michael Campbell’s MoneyTalks.
In the January 2, 2020 edition of TIMER DIGEST MAGAZINE, Mark Leibovit was ranked the #1 U.S. Stock Market Timer and was previously ranked #1 Intermediate U.S. Market Timer for the ten year period December, 1997 to 2007.
He was a ‘Market Maker’ on the Chicago Board Options Exchange and the Midwest Options Exchange and then went on to work in the Research department of two Chicago based brokerage firms. Mr. Leibovit now publishes a series of newsletters at www.LeibovitVRNewsletters.com. He became a member of the Market Technicians Association in 1982.
Mr. Leibovit’s specialty is Volume Analysis and his proprietary Leibovit Volume Reversal Indicator is well known for forecasting accurate signals of trend direction and reversals in the equity, metals and futures markets. He has historical experience recognizing, bull and bear markets and signaling alerts prior to market crashes. His indicator is currently available on the Metastock, and TradeStation platforms.
His comprehensive study on Volume Analysis, The Trader’s Book of Volume published by McGraw-Hill is a definitive guide to volume trading. It is now also published in Chinese. Mark has appeared in speaking engagements and seminars in the U.S. and Canada.
https://tinyurl.com/2rd9wv52
OPPORTUNITY TO ACCESS MARK LEIBOVIT’S PROPRIETARY VOLUME REVERSAL INDICATOR – THIS IS THE ONLY PLACE TO DO IT!
https://www.metastock.com/products/thirdparty/?3PC-ADD-VRIS
COME ON, DAD. IT’S TIME TO EAT
DISCLAIMER:
WE ARE NOT FINANCIAL ADVISORS AND DO NOT PROVIDE FINANCIAL ADVICE
The website, LeibovitVRNewsletters.com, is published by LeibovitVRNewsletters LLC.
In using LeibovitVRnewsletters.com (a/k/a LeibovitVRNewsletters LLC) you agree to these Terms & Conditions governing the use of the service. These Terms & Conditions are subject to change without notice. We are publishers and are not registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority.
All stocks and ETFs discussed are HYPOTHETICAL and not actual trades whose actual execution may differ markedly from prices posted on the website and in emails. This may be due internet connectivity, quote delays, data entry errors and other market conditions. Hypothetical or simulated performance results have certain inherent limitations as to liquidity and execution among other variables. PAST RESULTS ARE NOT NECESSARILY INDICATIVE OF FUTURE FORECASTING ACCURACY OR PROFITABLE TRADING RESULTS.
All investments are subject to risk, which should be considered on an individual basis before making any investment decision. We are not responsible for errors and omissions. These publications are intended solely for information and educational purposes only and the content within is not to be construed, under any circumstances, as an offer to buy or to sell or a solicitation to buy or sell or trade in any commodities or securities named within.
All commentary is provided for educational purposes only. This material is based upon information we consider reliable. However, accuracy is not guaranteed. Subscribers should always do their own investigation before investing in any security. Furthermore, you cannot be assured that your will profit or that any losses can or will be limited. It is important to know that no guarantee of any kind is implied nor possible where projections of future conditions in the markets are attempted.
Stocks and ETFs may be held by principals of LeibovitVRNewsletters LLC whose personal investment decisions including entry and exit points may differ from guidelines posted.
LeibovitVRNewsletters.com cannot and do not assess, verify or guarantee the suitability or profitability of any particular investment. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. As an express condition of using this service and anytime after ending the service, you agree not to hold LeibovitVRNewsletters.com or any employees liable for trading losses, lost profits or other damages resulting from your use of information on the Site in any form (Web-based, email-based, or downloadable software), and you agree to indemnify and hold LeibovitVRNewsletters.com and its employees harmless from and against any and all claims, losses, liabilities, costs, and expenses (including but not limited to attorneys’ fees) arising from your violation of this agreement. This paragraph is not intended to limit rights available to you or to us that may be available under the federal securities laws.
For rights, permissions, subscription and customer service, contact the publisher at mark.vrtrader@gmail.com or call at 928-282-1275 or mail to 10632 N. Scottsdale Road B-426, Scottsdale, AZ 85254.
The Leibovit Volume Reversal, Volume Reversal and Leibovit VR are registered trademarks.
© Copyright 2023. All rights reserved.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]